Lv4
412 积分 2025-03-14 加入
INTEGRATE IIa phase III study: Regorafenib for refractory advanced gastric cancer
14天前
已完结
De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer
17天前
已完结
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
23天前
已完结
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
1个月前
已完结
Gastric cancer
1个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
1个月前
已完结
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
1个月前
已完结
Targeting glutamine metabolism crosstalk with tumor immune response
1个月前
已完结
In Situ Reprogramming of Tumor-Associated Macrophages with Internally and Externally Engineered Exosomes
1个月前
已完结
Zolbetuximab + mFOLFOX6 as 1L treatment for patientswith CLDN18.2+/HER2-locally advanced (LA)unresectable or metastatic gastric or gastroesophageaiunction(mG/GEJ)adenocarcinoma: Primary phase 3results from SPOTLIGHT
1个月前
已完结
皖公网安备34019202002308
